Far East Pharmaceutical Technology Co. Ltd. (OTC: FEPTY)
|
|
---|---|
Pricing data not available |
Open: | $ n/a | Volume: | n/a | |
---|---|---|---|---|
High: | $ n/a | Yield(%) | n/a | |
Low: | $ n/a | P/E Ratio (ttm): | n/a | |
Dividend ($): | n/a | Market Cap ($): | n/a | |
EPS ($) | n/a | Shares Out: | n/a |
% Price Change (last 4 weeks): | 0.00 |
---|---|
% Price Change (last 13 weeks): | -76.00 |
% Price Change (last 26 weeks): | 0.00 |
% Price Change (last 52 weeks): | 0.00 |
% Price Change (year to date): | -100.00 |
Return on Equity (%): | n/a |
---|---|
Return on Assets (%): | -17.69 |
Return on Invested Capital (%): | -43.11 |
Gross Profit Margin (%): | 10.63 |
---|---|
Net Profit Margin (%): | -3042.70 |
Operating Profit Margin (%): | -256.98 |
50-day Moving Average: | $n/a |
---|---|
200-day Moving Average: | $n/a |
Avg. Daily Vol. (last 50 days): | n/a |
Avg. Daily Vol. (last 200 days): | n/a |
52-wk high: | $n/a |
52-wk low: | $n/a |
Bid: | $n/a |
Ask: | $n/a |
Innovative Pharmaceutical Biotech Ltd. is an investment holding company, which engages in genetic testing, healthcare management, and distribution of bio-industrial products. It also focuses on developing insulin product that could be administered orally. It operates through the Trading of Beauty Products, and Research and Development segments. The Trading of Beauty Products segment is involved in trading of beauty products. The Research and Development segment includes research, development, and commercialization of the oral insulin product. The company was founded in 2000 and is headquartered in Hong Kong.
|
Far East Pharmaceutical Technology Co. Ltd.
On Hong Commercial Building Unit 2002, 20th Floor 145 Hennessy Road, Wan Chai Hong Kong Phone: 852.2598.6818 Fax: 852.2598.6628 http://www.ipb.asia |
Earnings (1year) ($): | 0.55 |
---|---|
Annual Dividend ($): | 0.00 |
Current P/E Ratio (ttm): | n/a |
Book Value ($): | -6.92 |
Cash Flow ($): | -2.12 |
Price/Earnings (x): | n/a |
---|---|
Price/Sales (x): | 0.01 |
Price/Book (x): | n/a |
Price/Cash Flow (x): | n/a |
Quick Ratio (x): | 0.01 |
---|---|
Current Ratio (x): | 0.01 |
LT Debt/Equity (x): | n/a |
Total Debt/Equity (x): | n/a |